Company Overview of Merck Serono S.A.
Merck Serono S.A. discovers, develops, manufactures, and commercializes prescription medicines focusing on various therapeutic areas that include oncology, immuno-oncology, immunology, multiple sclerosis, fertility, endocrinology, biosimilars, and neglected diseases. It develop treatments to help manage neurodegenerative diseases, such as multiple sclerosis; colorectal cancer; drugs to treat head and neck cancer; fertility drugs for every stage of the reproductive cycle; specialized therapies to treat growth hormone deficiency in children and adults, as well as other related metabolic disorders; drug delivery devices; and drugs for treating diabetes, cardiovascular diseases, and thyroid diso...
Frankfurter Strasse 250
Founded in 1906
Key Executives for Merck Serono S.A.
Chief Executive Officer, President and Member of the Executive Board
Global Head of Legal, Senior VP of Merck Healthcare and General Counsel of Merck Healthcare
Global Head of Human Resources and Senior Vice-President
Global Head of Research & Development and Executive Vice President
Compensation as of Fiscal Year 2017.
Merck Serono S.A. Key Developments
Merck Serono S.A. Presents at Sachs Associates 10th Annual European Life Sciences CEO Forum & Exhibition, Mar-06-2017
Nov 30 16
Merck Serono S.A. Presents at Sachs Associates 10th Annual European Life Sciences CEO Forum & Exhibition, Mar-06-2017 . Venue: Hilton Zurich Airport Hotel, Hohenbuehlstrasse 10, Opfikon-Glattbrugg 8152 Zurich, Switzerland. Speakers: Joern-Peter Halle, Global Head of External Innovation.
Merck Serono S.A. Presents at 13th Annual BIO Asia International Conference 2016, Mar-15-2016
Mar 11 16
Merck Serono S.A. Presents at 13th Annual BIO Asia International Conference 2016, Mar-15-2016 . Venue: Grand Hyatt, Tokyo, Japan.
Merck Serono S.A. Presents at 8th Annual Biotech Showcase Investor Conference 2016, Jan-12-2016 12:00 PM
Dec 8 15
Merck Serono S.A. Presents at 8th Annual Biotech Showcase Investor Conference 2016, Jan-12-2016 12:00 PM. Venue: Parc 55 San Francisco, 55 Cyril Magnin Street, San Francisco, CA 94102, United States. Speakers: Philippe Lopes-Fernandes, Senior VP, Head, Global Licensing and Business Development.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|